Targeting peripheral serotonin receptor enhances antitumor immunity in colorectal cancer

◇ RESEARCH

Researchers developed IHCH-8110, a non-brain-penetrant 5-HT2AR agonist that activates serotonin receptors on enteric glial cells to promote CD8+ T cell recruitment and suppress colorectal cancer growth without psychedelic effects. (Cell)